Cargando…
Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast…
Since the 1950s, sodium polystyrene sulphonate (SPS) has been the dominant cation exchange agent prescribed for hyperkalaemia. Clinicians have had plenty of time to learn of SPS's advantages and limitations. The demands of drug regulatory agencies regarding the incorporation of medications into...
Autores principales: | Carrero, Juan Jesus, Sood, Manish M, Gonzalez-Ortiz, Ailema, Clase, Catherine M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387386/ https://www.ncbi.nlm.nih.gov/pubmed/37529644 http://dx.doi.org/10.1093/ckj/sfad089 |
Ejemplares similares
-
Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: primum non nocere!
por: Rossignol, Patrick, et al.
Publicado: (2023) -
The term CAKUT has outlived its usefulness: the case for the defense
por: Knoers, Nine V. A. M.
Publicado: (2022) -
Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry?
por: McCarron, David A.
Publicado: (2008) -
Is too much salt harmful? Yes
por: Agócs, Róbert, et al.
Publicado: (2019) -
Pro con debates in clinical medicine infection prevention and control in cystic fibrosis: One size fits all? The argument in favour
por: Haggie, S., et al.
Publicado: (2020)